Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More
AngioDynamics Inc. (NASDAQ: ANGO) was maintained as Buy at Janney Capital Markets, but the firm lowered its price target to $17.50 from $19.00 after saying that decent operating execution, notwithstanding soft top line, still justifies the rating.
Ashland Inc. (NYSE: ASH) was maintained as Buy but was removed from the prized Conviction Buy List at Goldman Sachs.
ArcelorMittal (NYSE: MT) was raised to Overweight from Neutral at JPMorgan.
Biomed Realty Trust Inc. (NYSE: BMR) was downgraded to Market Perform from Outperform at R.W. Baird.
CPI Aerostructures Inc. (NYSE: CVU) was started as Buy and was assigned a $12.00 price target (versus an $8.75 close) at Canaccord Genuity.
Digital Turbine Inc. (NASDAQ: APPS) was started with a Buy rating and $3.30 price target (versus a $1.92 close) at B. Riley.
DuPont Fabros Technology Inc. (NYSE: DFT) was started with a Buy rating and was assigned a $32.00 fair value estimate (versus a $27.46 close) at Janney Capital Markets.
Ecolab Inc. (NYSE: ECL) was downgraded to Neutral from Overweight with a $120 price target (versus a $120.53 close) at JPMorgan.
Franklin Resources Inc. (NYSE: BEN) was downgraded to Hold from Buy with a price target cut to $40 from $44 (versus a $38.89 close) at Deutsche Bank, based on expected outflows after five months of seeing such outflows.
Global Payments Inc. (NYSE: GPN) was downgraded to Hold from Buy but the price target was raised to $135 from $129 (versus a $132.45 close) at Jefferies.
Infinera Corp. (NASDAQ: INFN) was started as Equal Weight with a $21.00 price target (versus a $19.85 close) at Morgan Stanley.
Jabil Circuit Inc. (NYSE: JBL) was started with a Buy rating and was given a $29.00 price target (versus a $22.48 close) at B. Riley.
Monsanto Co. (NYSE: MON) was maintained as Buy at Argus after disappointing guidance, but the firm lowered its price target to $111 from $132 in the call (versus an $89.25 close).
Parker-Hannifin Corp. (NYSE: PH) was raised to Neutral from Underweight and the price target was raised to $103 from $98 (versus $106.81 close) at JPMorgan.
Twenty-First Century Fox Inc. (NASDAQ: FOXA) was started as Overweight with a price target of $32.00 (versus a $28.57 close) at Pacific Crest.
Zimmer Biomet Holdings Inc. (NYSE: ZBH) was started as Outperform with a $107 price target at Credit Suisse.
In case you missed Thursday’s top analyst upgrades and downgrades, they included Brookdale Senior Living, Dish Network, Groupon, Infinera, Medtronic, Pier 1 Imports, Tupperware, Yum Brands and over a dozen more.